NCT03084055

A Pilot Randomized Controlled Trial of an Intervention for Adults With Depression: the eMotion Study.

Completed NA Last updated 20 April 2018

What this trial tests

NA trial testing eMotion in Depressive Symptoms in 62 participants. Completed in 15 April 2017.

Timeline

1 May 2016

Primary endpoint
15 April 2017

15 April 2017

Quick facts

Lead sponsor	University of Exeter
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	62
Start date	1 May 2016
Primary completion	15 April 2017
Estimated completion	15 April 2017
Sites	1 location across United Kingdom

Drugs / interventions tested

• eMotion

Conditions studied

• Depressive Symptoms — all drugs for Depressive Symptoms →

Sponsor

University of Exeter

Who can join

18 and older, any sex, with Depressive Symptoms. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Physical activity has many potential mood enhancing benefits, and may be as effective as anti-depressants and psychological therapies for treating depression and low mood. However, getting people with depression to become more active is challenging. Behavioural Activation (BA) is an evidenced based psychotherapeutic treatment that focuses on increasing exposure to positive environmental stimuli which could provide an effective delivery mechanism for increasing physical activity for people who are more sedentary than the general population. The purpose of this study is to examine the feasibility of delivering a theory informed online intervention combining physical activity and BA (eMotion) to people with depression, and to examine its effects on depressive symptoms and physical activity.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

1. Web-Based Intervention Using Behavioral Activation and Physical Activity for Adults With Depression (The eMotion Study): Pilot Randomized Controlled Trial.
   Lambert JD, Greaves CJ, Farrand P, Price L, et al · · 2018 · cited 49× · PMID 30012547 · DOI 10.2196/10112